164 related articles for article (PubMed ID: 3113698)
21. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
Tajima S; Takehana M; Azuma N
J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
[TBL] [Abstract][Full Text] [Related]
22. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
[TBL] [Abstract][Full Text] [Related]
23. Altered ratio of collagen chains in bone of a patient with non-lethal osteogenesis imperfecta.
Sokolov BP; Sher BM; Hausmann J; Marik I; Deyl Z; Kalinin VN
Biochim Biophys Acta; 1992 Feb; 1138(2):93-6. PubMed ID: 1540665
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and degradation of collagen by skin fibroblasts from controls and from patients with osteogenesis imperfecta.
Steinmann BU; Martin GR; Baum BI; Crystal RG
FEBS Lett; 1979 May; 101(2):269-72. PubMed ID: 446751
[No Abstract] [Full Text] [Related]
25. Type 1 collagen synthesis by skin fibroblasts from 17 patients with osteogenesis imperfecta type III.
Pocock AE; Francis MJ; Smith R
Clin Chim Acta; 1995 Dec; 243(1):53-72. PubMed ID: 8747514
[TBL] [Abstract][Full Text] [Related]
26. Altered glycosaminoglycan production in cultured osteogenesis-imperfecta skin fibroblasts.
Turakainen H
Biochem J; 1983 Jul; 213(1):171-8. PubMed ID: 6615420
[TBL] [Abstract][Full Text] [Related]
27. Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies.
van der Rest M; Hayes A; Marie P; Desbarats M; Kaplan P; Glorieux FH
Am J Med Genet; 1986 Jul; 24(3):433-46. PubMed ID: 3728562
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfecta.
Nerlich AG; Brenner RE; Wiest I; Lehmann H; Yang C; Müller PK; von der Mark K
Am J Med Genet; 1993 Jan; 45(2):258-9. PubMed ID: 8456813
[TBL] [Abstract][Full Text] [Related]
29. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
Jensen BL; Lund AM
J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
[TBL] [Abstract][Full Text] [Related]
30. [Morphofunctional aspects of genetic analysis of osteogenesis imperfecta in cultured skin fibroblasts].
Meerson EM; Barer FS; Berezhnyĭ AP; Prokhorova EV; Maliavko TP; Chernysheva EV; Neustroeva EP
Biull Eksp Biol Med; 1992 Jul; 114(7):86-8. PubMed ID: 1421323
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of osteogenesis imperfecta. Biochemical and morphological findings in a case of type III according to Sillence.
Stöss H; Pontz BF; Pesch HJ; Ott R
Eur J Pediatr; 1986 Apr; 145(1-2):34-9. PubMed ID: 3732329
[TBL] [Abstract][Full Text] [Related]
32. Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta.
Vetter U; Weis MA; Mörike M; Eanes ED; Eyre DR
J Bone Miner Res; 1993 Feb; 8(2):133-7. PubMed ID: 8442432
[TBL] [Abstract][Full Text] [Related]
33. Phenotype variability in a daughter and father with mild osteogenesis imperfecta correlated with collagen and prolidase levels in cultured skin fibroblasts.
Galicka A; Surazyński A; Wołczyński S; Pałka J; Popko J; Gindzieński A
Ann Clin Biochem; 2005 Jan; 42(Pt 1):80-4. PubMed ID: 15802041
[TBL] [Abstract][Full Text] [Related]
34. Osteogenesis imperfecta (lethal) bones contain types III and V collagens.
Pope FM; Nicholls AC; Eggleton C; Narcissi P; Hey EN; Parkin JM
J Clin Pathol; 1980 Jun; 33(6):534-8. PubMed ID: 7400355
[TBL] [Abstract][Full Text] [Related]
35. [Osteogenesis imperfecta as an interdisciplinary medical problem].
Popko J; Galicka A; Wołczyński S; Zalewski W; Konstantynowicz J
Chir Narzadow Ruchu Ortop Pol; 2004; 69(4):235-9. PubMed ID: 15587378
[TBL] [Abstract][Full Text] [Related]
36. Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.
Bateman JF; Golub SB
Matrix Biol; 1994 Apr; 14(3):251-62. PubMed ID: 7921542
[TBL] [Abstract][Full Text] [Related]
37. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV.
Galicka A; Wolczynski S; Gindzienski A
J Pathol; 2002 Feb; 196(2):235-7. PubMed ID: 11793376
[TBL] [Abstract][Full Text] [Related]
39. Type V osteogenesis imperfecta: a new form of brittle bone disease.
Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
[TBL] [Abstract][Full Text] [Related]
40. Dental manifestations of osteogenesis imperfecta and abnormalities of collagen I metabolism.
Lund AM; Jensen BL; Nielsen LA; Skovby F
J Craniofac Genet Dev Biol; 1998; 18(1):30-7. PubMed ID: 9594376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
